| scholarly article | Q13442814 |
| P2093 | author name string | M C Terencio | |
| M Payá | |||
| S De Rosa | |||
| M Amigó | |||
| P2860 | cites work | Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer | Q24681630 |
| Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line | Q29547520 | ||
| NF-kappaB: a key role in inflammatory diseases | Q29617726 | ||
| Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. | Q31117251 | ||
| Capsaicin suppresses phorbol ester-induced activation of NF-kappaB/Rel and AP-1 transcription factors in mouse epidermis | Q31944109 | ||
| Psoriasis and the arachidonic acid cascade | Q33754811 | ||
| Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. | Q33826817 | ||
| FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. | Q46718326 | ||
| Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice | Q46951358 | ||
| The inflammatory response in mild and in severe psoriasis | Q47588154 | ||
| Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling | Q47598277 | ||
| Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation | Q48021812 | ||
| Large-scale production of pharmaceuticals by marine sponges: sea, cell, or synthesis? | Q51534882 | ||
| Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules. | Q53750553 | ||
| Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals | Q67493394 | ||
| Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids | Q69931802 | ||
| A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions | Q71874374 | ||
| Avarol and avarone, two new anti-inflammatory agents of marine origin | Q72020211 | ||
| Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue | Q72525706 | ||
| Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation | Q73393351 | ||
| Coordinate expression of secretory phospholipase A(2) and cyclooxygenase-2 in activated human keratinocytes | Q73634472 | ||
| SCH 47112, a novel staurosporine derivative, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and epidermal hyperplasia in hairless mouse skin | Q73815210 | ||
| Psoriasis: more than skin deep | Q81236496 | ||
| Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities | Q34327203 | ||
| The immunologic basis for the treatment of psoriasis with new biologic agents | Q34470558 | ||
| Novel immunotherapies for psoriasis | Q34500946 | ||
| Dimethylfumarate for psoriasis: more than a dietary curiosity | Q34554144 | ||
| Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model | Q34650903 | ||
| Involvement of NF-kappaB signalling in skin physiology and disease. | Q34980890 | ||
| Molecular design and biological activities of NF-kappaB inhibitors. | Q35005034 | ||
| Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis | Q35609103 | ||
| Antioxidant activity, lipid peroxidation and skin diseases. What's new. | Q35648220 | ||
| Biology of tumor necrosis factor-alpha- implications for psoriasis | Q35746601 | ||
| Secretory phospholipase A2. | Q35860497 | ||
| Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation | Q35864081 | ||
| The NF-kappaB signaling pathway in human genetic diseases | Q36144105 | ||
| Psoriasis: dysregulation of innate immunity | Q36158924 | ||
| A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis | Q36168350 | ||
| Mechanisms of action of topical therapies and the rationale for combination therapy | Q36169307 | ||
| Therapeutic options in the treatment of psoriasis and atopic dermatitis | Q36169320 | ||
| Oxidative stress in allergic and inflammatory skin diseases | Q36243117 | ||
| Innate and adaptive immunity and the pathophysiology of psoriasis | Q36400854 | ||
| NF-kappaB activation by reactive oxygen species: fifteen years later | Q36488422 | ||
| Signaling downstream of p38 in psoriasis. | Q36538074 | ||
| Both integrated and differential regulation of components of the IL-2/IL-2 receptor system | Q36566986 | ||
| Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes | Q38330398 | ||
| Potential antipsoriatic avarol derivatives as antioxidants and inhibitors of PGE(2) generation and proliferation in the HaCaT cell line | Q40512025 | ||
| MAPK regulation of prostaglandin E2 production by lipopolysaccharide-stimulated macrophages is not dependent on nuclear factor kappaB. | Q40637570 | ||
| Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides | Q40683243 | ||
| New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs | Q40752419 | ||
| Secretory and cytosolic phospholipase A(2)regulate the long-term cytokine-induced eicosanoid production in human keratinocytes | Q40863822 | ||
| Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. | Q41005171 | ||
| Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion | Q41343108 | ||
| Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages | Q41721933 | ||
| Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests | Q41912439 | ||
| Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skin. | Q42472979 | ||
| Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept | Q42479845 | ||
| Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo | Q42543352 | ||
| Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation | Q43628848 | ||
| TNF-alpha dependent NF-kappa B activation in cultured canine keratinocytes is partly mediated by reactive oxygen species | Q43649510 | ||
| A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase | Q43846877 | ||
| Pertussis toxin-sensitive secretory phospholipase A2 expression and motility in activated primary human keratinocytes | Q44282923 | ||
| The role of oxidants and antioxidants in psoriasis | Q44325916 | ||
| Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents | Q44823644 | ||
| Anti-inflammatory effects of tacalcitol (1,24(R)(OH)2D3, TV-02) in the skin of TPA-treated hairless mice | Q44929215 | ||
| Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. | Q46545785 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 353-365 | |
| P577 | publication date | 2007-07-16 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin | |
| P478 | volume | 152 |
| Q41331640 | Antipsoriatic activity of ethanolic extract of Woodfordia fruticosa (L.) Kurz flowers in a novel in vivo screening model |
| Q46956692 | Histamine enhances the production of human beta-defensin-2 in human keratinocytes |
| Q42526453 | IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q30870489 | Investigation of anti-oxidative stress in vitro and water apparent diffusion coefficient in MRI on rat after spinal cord injury in vivo with Tithonia diversifolia ethanolic extracts treatment |
| Q26740528 | Marine Natural Product Inhibitors of Neutrophil-Associated Inflammation |
| Q39433792 | NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. |
| Q95853676 | Phytochemical Screening and Metallic Ion Content and Its Impact on the Antipsoriasis Activity of Aqueous Leaf Extracts of Calendula officinalis and Phlebodium decumanum in an Animal Experiment Model |
| Q39169013 | Screening of flavonoid "quercetin" from the rhizome of Smilax china Linn. for anti-psoriatic activity |
| Q38256051 | Structure–activity relationship of terpenes with anti-inflammatory profile – a systematic review |
| Q27023252 | Targeting the redox balance in inflammatory skin conditions |
| Q60961982 | Three Constituents of Seeds Regulate Expression of Th17-Relevant Cytokines and Ameliorate TPA-Induced Psoriasis-Like Skin Lesions in Mice |
| Q48552332 | Topical Application of Glycolipids from Isochrysis galbana Prevents Epidermal Hyperplasia in Mice |
Search more.